Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001144204-07-050780

10% owner bought 679,048 shares at $1.05 ($713,000)

  • 10% owner sold 187,902 shares at an average $2.10 ($394,911)
  • 10% owner acquired 547,384 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

ADAMS DONALD E · 10% owner

Table I: Non-derivative

28 lines
Date Transaction Shares Price Value Owned after D/I
2006-06-08 Conversion : show line 1 in the form +518,657 $0.74 $382,250 5,006,250 D
2006-06-08 Conversion : show line 2 in the form +28,727 5,034,977 D
2006-08-11 Sale : show line 3 in the form −15,000 $1.13 $16,950 5,019,977 D
2007-01-16 Sale : show line 4 in the form −6,000 $1.22 $7,320 5,013,977 D
2007-01-17 Sale : show line 5 in the form −2,000 $1.23 $2,460 5,011,977 D
2007-01-22 Sale : show line 6 in the form −6,000 $1.20 $7,200 5,005,977 D
2007-01-24 Sale : show line 7 in the form −1,500 $1.20 $1,800 5,004,477 D
2007-01-27 Purchase : show line 8 in the form +679,048 $1.05 $713,000 5,683,525 D
Open-market purchases · 679,048 sh · avg $1.05 · $713,000
Open-market sales · 187,902 sh · avg $2.10 · $394,911

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2006-06-08 Conversion : show line 29 in the form $382,250 8% Convertible Note +547,384 $0.74 $403,422 $0.74 2006-11-26 547,384 0 D
Loading xslF345X02/v087678_ex.xml…